drugset

drugset / Trial / NCT02598362

Pharmacokinetics of Ciprofloxacin in Pediatric Patients

NCT02598362 ↗

Phase 4 Completed 22 enrolled University Hospital, Ghent Universitair Ziekenhuis Brussel · collab

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Measuring serum and urine concentrations of ciprofloxacin after IV and oral administration in children aged 3 months - 17 years who are treated for urinary tract infections.

Timeline

Start: 2015-04
Primary completion: 2017-05
Completion: 2017-10

Publications

Meesters K, Michelet R, Mauel R, Raes A, Van Bocxlaer J, Vande Walle J, Vermeulen A. Results of a Multicenter Population Pharmacokinetic Study of Ciprofloxacin in Children with Complicated Urinary Tract Infection. Antimicrob Agents Chemother. 2018 Aug 27;62(9):e00517-18. doi: 10.1128/AAC.00517-18. Print 2018 Sep.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ciprofloxacin	Small molecule	10 mg/kg	Intravenous
Subject	Ciprofloxacin	Small molecule	15 mg/kg	Intravenous
Subject	Ciprofloxacin	Small molecule	20 mg/kg	Intravenous

Indications